In the gastrointestinal field we focus in digestive probiotics for the treatment of:
– Disturbed microbiota equilibrium: that can lead to infections of opportunistic pathogens, causing different episodes such as diarrhea. There are different factors that leads to disbalance, such as illness and medications, i.e. antibiotics.
– Irritable Bowel Syndrome (IBS) , a functional bowel disorder in which recurrent abdominal pain is associated with defecation or a change in bowel habits, often associated to symptoms of abdominal bloating/distention. Research indicates that microbiota in people with IBS might differ from microbiota in healthy people.
The morbidity burden of IBS goes beyond specific gastrointestinal symptoms, increased pain perception (hyperalgesia) and increased worry about pain (gut-specific anxiety).
And altering the health-related quality of life (HRQoL).
Learn more about our products.
i3.1 is a 100% natural probiotic of human-origin, that has an innovative mechanism of action with a triple effect on the Irritable Bowel Syndrome (IBS) pathophysiology:
It's a 100% natural probiotic of human-origin for the improvement of gastrointestinal health.
Reduces the incidence and duration of diarrhea by various mechanisms of action: anti-inflammatory effect, strengthen of the intestinal epithelial barrier and antimicrobial and antiviral activity offering improved protection against pathogen-induced diarrhea.
Treatment and prevenction effectively of diarrhea associated with the intake of antibiotics (AAD).